Nuclear Medicine Advances Highlighted At Abu Dhabi Conference On Precision Imaging And Therapy

The "Advances in Nuclear Medicine: Precision Imaging and Therapy 2026" conference has opened in Abu Dhabi, organised by Burjeel Cancer Institute. The meeting brings together more than 300 experts to review new nuclear medicine applications in cancer diagnosis and treatment. The event also highlights Abu Dhabi’s role as a regional centre for specialised medical conferences and advanced oncology services.

Organisers state that the conference supports Abu Dhabi’s ambitions to strengthen cancer care and clinical research. By presenting recent scientific evidence and technologies, the gathering aims to improve diagnostic accuracy, support targeted treatment decisions, and raise patients’ quality of life. The agenda is aligned with the emirate’s strategy to develop as a regional and international reference point for oncology.

The scientific programme combines lectures, practical sessions, and case-based discussions. Sessions address how nuclear medicine integrates into full oncology care pathways, from first diagnosis to follow-up. Topics include assessment of metabolic response to therapy and multidisciplinary decision-making. Presentations place strong emphasis on how evidence-based imaging and therapy can influence real outcomes in daily clinical practice.

Speakers review advanced imaging tools such as PET/CT and SPECT/CT, alongside newer radiotracers and theranostic approaches. Discussions also consider how nuclear medicine supports early detection and management across several diseases. These include many cancers, cardiovascular conditions, endocrine disorders, and other complex illnesses, where functional imaging offers information that conventional diagnostic methods may not provide alone.

More than 300 participants are attending from the United Arab Emirates and abroad, representing a wide range of disciplines. Delegates include specialists in surgery, medical oncology, gastroenterology, urology, endocrinology, neurology, radiation oncology, bone marrow, and orthopedics, in addition to regional and international experts in nuclear medicine and oncology.

Advances in Nuclear Medicine Conference 2026 impact on precision imaging and therapy

Professor Humaid bin Harmal Al Shamsi, CEO of Burjeel Cancer Institute and Conference President, notes that hosting this specialised meeting in Abu Dhabi reflects the institute’s support for scientific exchange. Professor Humaid explains that updated knowledge in nuclear medicine helps improve clinical decisions, refine treatment planning, and enhance patient outcomes, while also strengthening Abu Dhabi’s position in advanced cancer care.

Dr. Ibrahim Abu Gheida, Chief Medical Officer of Burjeel Cancer Institute and Chairman of the Scientific Committee, states that the programme is designed to link theory with hands-on practice. Real clinical cases are used to review best practices, allowing physicians and healthcare workers to relate published evidence to daily work and adapt international guidelines to local clinical settings.

Interim Head of the Nuclear Medicine Department at Burjeel Medical City and Chair of the Organising Committee, Dr. Firuz Ibrahim, stresses that rapid advances in nuclear medicine have changed how tumours are diagnosed and treated. Dr. Firuz highlights that these tools support precise, personalised care, limit unnecessary procedures, and strengthen safety. The conference also aligns with Burjeel Cancer Institute’s efforts to promote continuous education and multidisciplinary collaboration in Abu Dhabi.

With inputs from WAM